Tumour organoids predict bowel cancer treatment response
Patient-derived tumour organoids can predict how effectively patients with bowel cancer will respond to drug treatment, according to a new study...
An approach to medicine based on grouping patients according to the characteristics of their disease or how they respond to particular treatments (or to prophylaxis). This enables the identification and development of measures that are most effective for particular groups of patients.
Patient-derived tumour organoids can predict how effectively patients with bowel cancer will respond to drug treatment, according to a new study...
A comprehensive map of genetic vulnerabilities in cancer has revealed targets for the development of novel anti-cancer drugs...
Using whole genome sequencing and clinical data aids the delivery of personalised cancer care, landmark study shows...
US men with prostate cancer could be missing out on targeted treatments because they do not meet the current guidelines for genetic testing...
DNA, Children and Young People's Health Resource is the world's first national research programme aimed at furthering understanding of how children's genes determine their physical and mental health...
A specific gene allele may contribute to the higher severity of stroke seen among black populations, and also the reason they are less responsive to commonly used stroke medications...
A biobank scheme will be piloted in England to study links between patients' genomes and their risk of adverse drug reactions...
Dr Beatrice Costa reviews a BBC Radio 4 drama which explores the implications of a genetic condition that doubles an individual's lifespan...
Patients experienced 30 percent fewer serious side effects when their prescribed medication was tailored to their DNA profile by using a 'DNA medication pass'...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.